Arax Advisory Partners’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Arax Advisory Partners's HALO Position: Q2 2026 in Review
Arax Advisory Partners increased its Halozyme (HALO) stake by 712% in Q2 2026, buying an estimated $168K and bringing the position to 2,810 shares worth $220K. The position accounts for ﹤0.01% of the portfolio, ranked #2189.
Arax Advisory Partners first reported a position in HALO in Q4 2021 and has held it in 19 quarters since. The position peaked at $460K in Q3 2025. 668 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Arax Advisory Partners held 2,810 shares of Halozyme worth $220K as of Q2 2026.
- Arax Advisory Partners bought 2,464 Halozyme shares in Q2 2026, an estimated $168K.
- Halozyme made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #2189 holding.
- Arax Advisory Partners first reported a position in Halozyme in Q4 2021 and has held it in 19 quarters since.
- Arax Advisory Partners's Halozyme position peaked at $460K in Q3 2025.
- 668 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.